Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Rohit ThakurJonathan P LayeMartin LaussJoey Mark S DiazSally Jane O'SheaJoanna PoźniakAnastasia FiliaMark HarlandJoanne GascoyneJuliette A Randerson-MoorMay ChanTracey MellGöran JönssonD Timothy BishopJulia A Newton-BishopJennifer H BarrettJérémie NsengimanaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
A transcriptomic signature of primary melanoma was identified with prognostic value, including in stage I melanoma and in patients undergoing immunotherapy.